192 related articles for article (PubMed ID: 9987734)
1. GnRH agonist. Increasing the pregnancy rate after combined treatment with hMG/hCG and direct intraperitoneal insemination.
Minoura H; Takeuchi S; Shen X; Shibahara T; Futamura N; Toyoda N
J Reprod Med; 1999 Jan; 44(1):18-22. PubMed ID: 9987734
[TBL] [Abstract][Full Text] [Related]
2. A spontaneous luteinizing hormone surge is beneficial in women with unexplained infertility undergoing controlled ovarian hyperstimulation without in vitro fertilization.
Costello MF; Hughes GJ; Garrett DK; Hanjani A; Steigrad SJ
Int J Fertil Womens Med; 1998; 43(1):28-33. PubMed ID: 9532467
[TBL] [Abstract][Full Text] [Related]
3. [Controlled hyperstimulation in intra-uterine inseminations: hMG-hCG protocol (204 cycles)].
Abboud P; Delépine B; Pigeon F; Bednarczyk L; Quéreux C
Contracept Fertil Sex; 1997 Jun; 25(6):463-9. PubMed ID: 9280551
[TBL] [Abstract][Full Text] [Related]
4. [Application of ultra-short gonadotropin-releasing hormone agonist protocol in controlled ovarian hyperstimulation].
Zhao X; Zhang L; Gong S
Zhonghua Fu Chan Ke Za Zhi; 1997 Oct; 32(10):589-92. PubMed ID: 9642373
[TBL] [Abstract][Full Text] [Related]
5. GnRH agonist (buserelin) or hCG for ovulation induction in GnRH antagonist IVF/ICSI cycles: a prospective randomized study.
Humaidan P; Bredkjaer HE; Bungum L; Bungum M; Grøndahl ML; Westergaard L; Andersen CY
Hum Reprod; 2005 May; 20(5):1213-20. PubMed ID: 15760966
[TBL] [Abstract][Full Text] [Related]
6. Superovulation and intrauterine insemination vs. superovulation alone in the treatment of unexplained infertility. A randomized study.
Arcaini L; Bianchi S; Baglioni A; Marchini M; Tozzi L; Fedele L
J Reprod Med; 1996 Aug; 41(8):614-8. PubMed ID: 8866392
[TBL] [Abstract][Full Text] [Related]
7. Treating infertility. Controlled ovarian hyperstimulation using human menopausal gonadotropin in combination with intrauterine insemination.
Vollenhoven B; Selub M; Davidson O; Lefkow H; Henault M; Serpa N; Hung TT
J Reprod Med; 1996 Sep; 41(9):658-64. PubMed ID: 8887190
[TBL] [Abstract][Full Text] [Related]
8. A novel, simplified and cost effective protocol for superovulation and intrauterine insemination.
Williams RS; Kipersztok S; Hills D; Dattilo M
J Fla Med Assoc; 1997; 84(5):316-9. PubMed ID: 9260436
[TBL] [Abstract][Full Text] [Related]
9. Cycle fecundity in controlled ovarian hyperstimulation and intrauterine insemination. Influence of the number of mature follicles at hCG administration.
Kaplan PF; Katz SL; Thompson AK; Freund RD
J Reprod Med; 2002 Jul; 47(7):535-9. PubMed ID: 12170528
[TBL] [Abstract][Full Text] [Related]
10. No difference in cycle pregnancy rate and in cumulative live-birth rate between women with surgically treated minimal to mild endometriosis and women with unexplained infertility after controlled ovarian hyperstimulation and intrauterine insemination.
Werbrouck E; Spiessens C; Meuleman C; D'Hooghe T
Fertil Steril; 2006 Sep; 86(3):566-71. PubMed ID: 16952506
[TBL] [Abstract][Full Text] [Related]
11. Impact of leuprolide acetate on luteal phase function in women undergoing controlled ovarian hyperstimulation and intrauterine insemination.
Duffy DA; Manzi D; Benadiva C; Maier D; Saunders M; Nulsen J
Fertil Steril; 2006 Feb; 85(2):407-11. PubMed ID: 16595219
[TBL] [Abstract][Full Text] [Related]
12. The efficacy of nafarelin acetate versus leuprolide acetate in conjunction with human menopausal gonadotropins for superovulation/intrauterine insemination.
Schmidt-Sarosi CL; Yerovi LA
Int J Fertil Menopausal Stud; 1994; 39(1):20-5. PubMed ID: 8167676
[TBL] [Abstract][Full Text] [Related]
13. Clomiphene citrate intrauterine insemination (IUI) before gonadotropin IUI affects the pregnancy rate and the rate of high-order multiple pregnancies.
Dickey RP; Taylor SN; Lu PY; Sartor BM; Pyrzak R
Fertil Steril; 2004 Mar; 81(3):545-50. PubMed ID: 15037400
[TBL] [Abstract][Full Text] [Related]
14. Timing intrauterine insemination either 33 or 39 hours after administration of human chorionic gonadotropin yields the same pregnancy rates as after superovulation therapy.
Claman P; Wilkie V; Collins D
Fertil Steril; 2004 Jul; 82(1):13-6. PubMed ID: 15236979
[TBL] [Abstract][Full Text] [Related]
15. Does the addition of a gonadotropin-releasing hormone agonist improve the pregnancy rate in intrauterine insemination? A prospective controlled trial.
Eskandar MA
Gynecol Endocrinol; 2007 Oct; 23(10):551-5. PubMed ID: 17891598
[TBL] [Abstract][Full Text] [Related]
16. Addition of gonadotrophin-releasing hormone agonist and/or two inseminations with husband's sperm do not improve the pregnancy rate in superovulated cycles.
Karlström PO; Bergh T; Lundkvist O
Acta Obstet Gynecol Scand; 2000 Jan; 79(1):37-42. PubMed ID: 10646814
[TBL] [Abstract][Full Text] [Related]
17. A randomized and longitudinal study of human menopausal gonadotropin with intrauterine insemination in the treatment of infertility.
Nulsen JC; Walsh S; Dumez S; Metzger DA
Obstet Gynecol; 1993 Nov; 82(5):780-6. PubMed ID: 8414326
[TBL] [Abstract][Full Text] [Related]
18. Lyophilised hMG versus rFSH in women with unexplained infertility undergoing a controlled ovarian stimulation with intrauterine insemination: a prospective, randomised study.
Kocak M; Dilbaz B; Demir B; Taşci Y; Tarcan A; Dede S; Haberal A
Gynecol Endocrinol; 2010 Jun; 26(6):429-34. PubMed ID: 20175705
[TBL] [Abstract][Full Text] [Related]
19. Double vs. single intrauterine insemination per cycle: use in gonadotropin cycles and in diagnostic categories of ovulatory dysfunction and male factor infertility.
Randall GW; Gantt PA
J Reprod Med; 2008 Mar; 53(3):196-202. PubMed ID: 18441725
[TBL] [Abstract][Full Text] [Related]
20. Comparison of different gonadotrophin preparations in intrauterine insemination cycles for the treatment of unexplained infertility: a prospective, randomized study.
Demirol A; Gurgan T
Hum Reprod; 2007 Jan; 22(1):97-100. PubMed ID: 16954409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
